Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Citomed Oy
OY
Active
Y-tunnus 0733952-5
Rovastintie 40, 35100
Orivesi As
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1989 · 37 years old
— employees
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Citomed Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
1M
1M
1M
0M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 1M (0% vs 2023)
1M
0%
2024
2025: 1M (0% vs 2024)
1M
0%
2025
EBITDA
EUR millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
EUR thousands
Item
2025
2024
2023
2022
2021
Revenue
1 309
621
630
888
1 177
Staff expenses
−1
−5
−0
—
−0
EBITDA
368
147
148
211
337
Depreciation & amort.
−51
−59
−54
−81
−79
EBIT
316
88
94
130
258
Net financials
−3
−7
−9
−4
−8
Profit before tax
313
81
85
125
250
Tax
62
16
17
27
50
Net profit
251
65
67
99
200
Balance sheet
EUR thousands
Item
2025
2024
2023
2022
2021
Total assets
1 116
988
1 028
1 117
1 238
Equity
254
81
70
103
724
Long-term debt
74
85
134
110
165
Short-term debt
789
822
825
904
349
Total debt
863
907
958
1 014
514
Financial ratios
5-year trend
EBITDA margin
28,1 %
This company
15,8 %
Market median
This company
Market median
78% above market
2021
2025
Equity ratio
22,7 %
This company
38,2 %
Market median
This company
Market median
41% below market
2021
2025
Return on equity
99,0 %
This company
18,4 %
Market median
This company
Market median
438% above market
2021
2025
Net profit margin
19,2 %
This company
8,1 %
Market median
This company
Market median
137% above market
2021
2025
Asset turnover
1,17×
This company
1,12×
Market median
This company
Market median
4% above market
2021
2025
Debt / equity
3,40×
This company
0,62×
Market median
This company
Market median
448% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on Citomed Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
